Kovitz Investment Group Partners, LLC Humacyte, Inc. Transaction History

Kovitz Investment Group Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$1.99 - $3.12 $24,377 - $38,220	12,250 New	12,250 $34,000
Q1 2023 May 11, 2023	BUY	$2.11 - $3.25 $23,737 - $36,562	11,250 New	11,250 $35,000
Q1 2022 Apr 22, 2022	BUY	$4.65 - $7.4 $53,707 - $85,470	11,550 New	11,550 $82,000
Q4 2021 Feb 04, 2022	SELL	$7.25 - $11.6 $80,112 - $128,180	-11,050 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$9.21 - $16.99 $101,770 - $187,739	11,050 New	11,050 $128,000

149

35.1M

279K

607K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $475M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.